Page 2 - Breast Program News Today

Terry P. Mamounas, MD, discusses surgical de-escalation strategies in the treatment of patients with HER2-positive breast cancer.

Every year, about 240,000 cases of breast cancer are diagnosed in the US, and 42,000 woman die from the disease, according to the CDC.

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...

For the 11th consecutive year, OncLive is honored to recognize oncology leaders whose innovations have contributed to immeasurable improvements in outcomes for countless patients.

The National Accreditation Program for Breast Centers, a quality program administered by the American College of Surgeons, re-accredited Marietta Memorial Hospi

MARIETTA — The National Accreditation Program for Breast Centers, a quality program administered by the American College of Surgeons, re-accredited Marietta M

Intracavity, real-time assessment of margins using a novel imaging agent and visualization system may improve complete resection rates, new findings show.

A new technique designed to allow surgeons to identify and remove residual tumor tissue during breast-conserving surgery showed promising results in a multi-center trial led by investigators from the Mass General Cancer Center, a member of Mass General Brigham.

The system is considered effective at identifying residual breast cancer following surgical resection.

Novel optical imaging agent highlights cancerous tissue during initial lumpectomy to enable a more complete resection as part of the investigational Lumicell Direct Visualization System